← Al het nieuws

Apply for the Henri Termeer Fellowship Class of 2024 

,

The Termeer Foundation, an organization that connects global life sciences innovators and builds upon Henri Termeer’s legacy, is offering an opportunity for bio-pharma CEOs through a fellowship. This fellowship entails a unique leadership program and access to an extensive network comprising global fellows, CEOs, and founders of innovative biotech companies. Are you the next emerging biotech entrepreneur of the Netherlands or Massachusetts? Then you have a chance to win this fellowship via the prestigious 4th Henri Termeer Transatlantic Connections Award. Apply here before the 5th of January 2024.

About the Henri Termeer Transatlantic Connections Award 

The Henri Termeer Transatlantic Connections Award is established by The Termeer Foundation, in partnership with Health~Holland, to honor and recognize two emerging biotech entrepreneurs: one in Massachusetts and one in the Netherlands. Awardees become members of the 2024 Class of Termeer Fellows and join the Termeer network, an ever-expanding network of biotech entrepreneurs, CEOs and visionaries and recognition at the annual Termeer Fellows Celebration. 

Awardees lead innovative biomedical research activities, and their programs have the potential to strengthen the transatlantic relation between the two life sciences regions. Candidates will be selected based upon their entrepreneurial success in establishing a life science company that meets certain criteria like leadership capabilities, scientific and financial track record. Next to that, they exhibit a strong interest in mentoring other young entrepreneurs and a willingness for additional involvement in the Termeer Foundation Programs. 

Reach a fellowship status via another application process  

Next to the Award, you can also reach a Termeer Fellowship status through the Termeer Fellowship application. This is exclusively for first-time CEOs of early-stage biotech companies. You’ll read more about the procedure and conditions in the brochure below.